|
Gene ID | Gene symbol | Full name |
|
6256 | RXRA | Retinoid X receptor, alpha |
3309 | HSPA5 | Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) |
3320 | HSP90AA1 | Heat shock protein 90 kDa alpha (cytosolic), class A member 1 |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
6778 | STAT6 | Signal transducer and activator of transcription 6, interleukin-4 induced |
3146 | HMGB1 | High-mobility group box 1 |
3301 | DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
4221 | MEN1 | Multiple endocrine neoplasia I |
3312 | HSPA8 | Heat shock 70 kDa protein 8 |
3840 | KPNA4 | Karyopherin alpha 4 (importin alpha 3) |
2274 | FHL2 | Four-and-a-half LIM domains 2 |
4792 | NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
57805 | KIAA1967 | KIAA1967 |
3185 | HNRNPF | Heterogeneous nuclear ribonucleoprotein F |
203068 | TUBB | Tubulin, beta |
6774 | STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) |
4670 | HNRNPM | Heterogeneous nuclear ribonucleoprotein M |
1997 | ELF1 | E74-like factor 1 (ets domain transcription factor) |
113457 | TUBA3D | Tubulin, alpha 3D |
1999 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific) |
5591 | PRKDC | Protein kinase, DNA-activated, catalytic polypeptide |
708 | C1QBP | Complement component 1, q subcomponent binding protein |
2274 | FHL2 | Four-and-a-half LIM domains 2 |
3313 | HSPA9 | Heat shock 70 kDa protein 9 (mortalin) |
8600 | TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 |
3659 | IRF1 | Interferon regulatory factor 1 |
84617 | TUBB6 | Tubulin, beta 6 |
7280 | TUBB2A | Tubulin, beta 2A |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
8517 | IKBKG | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
7295 | TXN | Thioredoxin |
10318 | TNIP1 | TNFAIP3 interacting protein 1 |
4793 | NFKBIB | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
3065 | HDAC1 | Histone deacetylase 1 |
3551 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
1152 | CKB | Creatine kinase, brain |
4069 | LYZ | Lysozyme (renal amyloidosis) |
140462 | ASB9 | Ankyrin repeat and SOCS box-containing 9 |
4653 | MYOC | Myocilin, trabecular meshwork inducible glucocorticoid response |
6774 | STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) |
3660 | IRF2 | Interferon regulatory factor 2 |
7278 | TUBA3C | Tubulin, alpha 3c |
4221 | MEN1 | Multiple endocrine neoplasia I |
5966 | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) |
1147 | CHUK | Conserved helix-loop-helix ubiquitous kinase |
55922 | NKRF | NFKB repressing factor |
2113 | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
64332 | NFKBIZ | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
51773 | RSF1 | Remodeling and spacing factor 1 |
5971 | RELB | v-rel reticuloendotheliosis viral oncogene homolog B |
1832 | DSP | Desmoplakin |
347733 | TUBB2B | Tubulin, beta 2B |
2353 | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog |
9325 | TRIP4 | Thyroid hormone receptor interactor 4 |
4435 | CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
22984 | PDCD11 | Programmed cell death 11 |
790 | CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
1326 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 |
1917 | EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 |
9172 | MYOM2 | Myomesin (M-protein) 2, 165 kDa |
10856 | RUVBL2 | RuvB-like 2 (E. coli) |
1158 | CKM | Creatine kinase, muscle |
808 | CALM3 | Calmodulin 3 (phosphorylase kinase, delta) |
672 | BRCA1 | Breast cancer 1, early onset |
801 | CALM1 | Calmodulin 1 (phosphorylase kinase, delta) |
293 | SLC25A6 | Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 |
3310 | HSPA6 | Heat shock 70 kDa protein 6 (HSP70B′) |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
136319 | MTPN | Myotrophin |
2274 | FHL2 | Four-and-a-half LIM domains 2 |
9093 | DNAJA3 | DnaJ (Hsp40) homolog, subfamily A, member 3 |
4628 | MYH10 | Myosin, heavy chain 10, non-muscle |
4221 | MEN1 | Multiple endocrine neoplasia I |
6774 | STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) |
3839 | KPNA3 | Karyopherin alpha 3 (importin alpha 4) |
57805 | KIAA1967 | KIAA1967 |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
1869 | E2F1 | E2F transcription factor 1 |
55662 | HIF1AN | Hypoxia-inducible factor 1, alpha subunit inhibitor |
79155 | TNIP2 | TNFAIP3 interacting protein 2 |
9532 | BAG2 | BCL2-associated athanogene 2 |
6421 | SFPQ | Splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
10627 | MRCL3 | Myosin regulatory light chain MRCL3 |
7431 | VIM | Vimentin |
672 | BRCA1 | Breast cancer 1, early onset |
2274 | FHL2 | Four-and-a-half LIM domains 2 |
4221 | MEN1 | Multiple endocrine neoplasia I |
672 | BRCA1 | Breast cancer 1, early onset |
4221 | MEN1 | Multiple endocrine neoplasia I |
3836 | KPNA1 | Karyopherin alpha 1 (importin alpha 5) |
3093 | UBE2K | Ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast) |
805 | CALM2 | Calmodulin 2 (phosphorylase kinase, delta) |
5970 | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
9782 | MATR3 | Matrin 3 |
8600 | TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 |
8607 | RUVBL1 | RuvB-like 1 (E. coli) |
4627 | MYH9 | Myosin, heavy chain 9, nonmuscle |
23421 | ITGB3BP | Integrin beta 3 binding protein (beta3-endonexin) |
140462 | ASB9 | Ankyrin repeat and SOCS box-containing 9 |
4841 | NONO | Non-POU domain containing, octamer-binding |
9276 | COPB2 | Coatomer protein complex, subunit beta 2 (beta prime) |
4221 | MEN1 | Multiple endocrine neoplasia I |
1213 | CLTC | Clathrin, heavy chain (Hc) |
292 | SLC25A5 | Solute carrier family 25 (Mitochondrial carrier; adenine nucleotide translocator), member 5 |
4066 | LYL1 | Lymphoblastic leukemia-derived sequence 1 |
64332 | NFKBIZ | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
5531 | PPP4C | Protein phosphatase 4 (formerly X), catalytic subunit |
8091 | HMGA2 | High-mobility group AT-hook 2 |
6202 | RPS8 | Ribosomal protein S8 |
1051 | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
222643 | UNC5CL | Unc-5 homolog C (C. elegans)-like |
4790 | NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
71 | ACTG1 | Actin, gamma 1 |
3312 | HSPA8 | Heat shock 70 kDa protein 8 |
9782 | MATR3 | Matrin 3 |
3320 | HSP90AA1 | Heat shock protein 90 kDa alpha (cytosolic), class A member 1 |
4637 | MYL6 | Myosin, light chain 6, alkali, smooth muscle and nonmuscle |
2908 | NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
4793 | NFKBIB | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
688 | KLF5 | Kruppel-like factor 5 (intestinal) |
672 | BRCA1 | Breast cancer 1, early onset |
|